不同的皮质类固醇在严重的社区获得性肺炎中的比较效果:一个网络元分析
Liangdong Zhu1, Jia Zeng2, Hui Li1
1The First Hospital of Changsha, Changsha, China.
BMC pulmonary medicine
|April 30, 2025
概括
皮可以有效地降低严重社区获得性肺炎 (CAP) 的死亡率. 这种皮质类固醇还降低了CAP患者机械通风的需要.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的社区性肺炎 (CAP) 是一种危及生命的疾病.
- 对严重CAP的皮质类固醇疗效和安全性报告不一致.
- 缺乏证据来对不同类型的皮质类固醇进行严重的CAP治疗.
研究的目的:
- 评估不同类型的皮质类固醇对严重CAP患者的影响.
- 为了比较各种皮质类固醇的疗效和安全性.
- 为在严重的CAP中提供最佳皮质类固醇选择的证据.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和Web of Science进行全面的文献搜索,截至2024年3月31日.
- 包含随机对照试验 (RCT),将皮质类固醇与安慰剂进行比较,用于严重的CAP.
- 主要结局:全因死亡率;次要结局:机械通风 (MV) 和严重不良事件 (SAE).
主要成果:
- 有2042名参与者参加的11个RCT比较了皮松,甲,普雷迪尼索隆和甲基普雷迪尼索隆与安慰剂.
- 皮显著降低了所有原因的死亡率 (RR,0.35;95%CRI,0.14-0.64) 和需要MV的需要 (RR,0.73;95%CRI,0.51-0.93).
- 亚组分析表明,低至中等剂量和短期皮质类固醇降低了死亡率和MV需求.
结论:
- 皮似乎是一种有效的皮质类固醇,可以降低严重CAP的死亡率.
- 低至中等剂量,短期皮质类固醇治疗方案可能对严重的CAP有益.
- 进一步的研究可能会澄清严重CAP的最佳皮质类固醇策略.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
01:29Pneumonia II: Pathophysiology
175
The pathophysiology of pneumonia involves the following steps:
175
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.4K
01:30Pneumonia III: Complications and Assessment
116
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
116
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K